Implementing a Clinical Decision Support Tool to Increase Early Peanut Introduction Guidance.

allergy clinical decision support early peanut introduction electronic health records peanut peanut introduction simulation user-centered design

Journal

The Journal of allergy and clinical immunology
ISSN: 1097-6825
Titre abrégé: J Allergy Clin Immunol
Pays: United States
ID NLM: 1275002

Informations de publication

Date de publication:
10 Jul 2024
Historique:
received: 19 03 2024
revised: 15 06 2024
accepted: 09 07 2024
medline: 13 7 2024
pubmed: 13 7 2024
entrez: 12 7 2024
Statut: aheadofprint

Résumé

General pediatric providers are the frontline for early peanut introduction discussions, but many feel ill-equipped to handle such discussions as guidelines have quickly changed. We hypothesized that a clinical decision support (CDS) tool could improve peanut introduction discussions. CDS tools were designed by stakeholders, improved through usability testing, and integrated into the current note templates. Based on queries of electronic health record (EHR), we did a pre-post performance evaluation of peanut introduction conversations, barriers for introduction, and percentage of 12-month WCC visits that had successfully introduced peanut. Providers completed surveys before and after intervention to assess awareness of early peanut introduction and comfort using CDS. Providers' awareness of early peanut introduction guidelines increased from 17.8% to 66.7% after the CDS tool was implemented. 79.1% were comfortable using the tool. The CDS tool improved peanut introduction conversations at the 4-month well-child (WCC) care visit from 2.4% to 81.2%, at the 6-month WCC visit from 3.0% to 84.2%, and at the 12-month WCC visit from 2.7% to 82.9%. 56.6% of families had a plan to introduce peanut at the 4-month WCC visit. Of those who did not have a plan, the most common barrier was family's unawareness of the benefits of early peanut introduction. At the 12-month visit, 62.8% of families had introduced peanut without concerns. A point-of-care CDS tool encouraged more discussions by general pediatric providers on early peanut introduction to all patients. CDS tools should be considered in quality improvement projects as an implementation method for the most up-to-date guidelines.

Sections du résumé

BACKGROUND BACKGROUND
General pediatric providers are the frontline for early peanut introduction discussions, but many feel ill-equipped to handle such discussions as guidelines have quickly changed.
OBJECTIVE OBJECTIVE
We hypothesized that a clinical decision support (CDS) tool could improve peanut introduction discussions.
METHODS METHODS
CDS tools were designed by stakeholders, improved through usability testing, and integrated into the current note templates. Based on queries of electronic health record (EHR), we did a pre-post performance evaluation of peanut introduction conversations, barriers for introduction, and percentage of 12-month WCC visits that had successfully introduced peanut. Providers completed surveys before and after intervention to assess awareness of early peanut introduction and comfort using CDS.
RESULTS RESULTS
Providers' awareness of early peanut introduction guidelines increased from 17.8% to 66.7% after the CDS tool was implemented. 79.1% were comfortable using the tool. The CDS tool improved peanut introduction conversations at the 4-month well-child (WCC) care visit from 2.4% to 81.2%, at the 6-month WCC visit from 3.0% to 84.2%, and at the 12-month WCC visit from 2.7% to 82.9%. 56.6% of families had a plan to introduce peanut at the 4-month WCC visit. Of those who did not have a plan, the most common barrier was family's unawareness of the benefits of early peanut introduction. At the 12-month visit, 62.8% of families had introduced peanut without concerns.
CONCLUSION CONCLUSIONS
A point-of-care CDS tool encouraged more discussions by general pediatric providers on early peanut introduction to all patients. CDS tools should be considered in quality improvement projects as an implementation method for the most up-to-date guidelines.

Identifiants

pubmed: 38996876
pii: S0091-6749(24)00712-7
doi: 10.1016/j.jaci.2024.07.005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Annabelle F Rowland (AF)

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.

Thinh H Nguyen (TH)

Division of Immunology, Boston Children's Hospital, Boston, MA, United States.

Priscila P Cunha (PP)

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.

Idil Ezhuthachan (I)

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.

Evan Orenstein (E)

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States; Division of Hospital Medicine, Children's Healthcare of Atlanta, Atlanta, GA, United States.

Swaminathan Kandaswamy (S)

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.

Tricia Lee (T)

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States; Children's Healthcare of Atlanta, Atlanta, GA, United States. Electronic address: tricia.lee2@emory.edu.

Classifications MeSH